EF24, a synthetic monocarbonyl analog of curcumin, shows significant potential as an anticancer agent with both chemopreventive and chemotherapeutic properties. It exhibits rapid absorption, extensive tissue distribution, and efficient metabolism, ensuring optimal bioavailability and sustained exposure of the target tissues. The ability of EF24 to penetrate biological barriers and accumulate at tumor sites makes it advantageous for effective cancer treatment. Studies have demonstrated EF24’s remarkable efficacy against various cancers, including breast, lung, prostate, colon, and pancreatic cancer. The unique mechanism of action of EF24 involves modulation of the nuclear factor-kappa B (NF-κB) and nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathways, disrupting cancer-promoting inflammation and oxidative stress. EF24 inhibits tumor growth by inducing cell cycle arrest and apoptosis, mainly through inhibiting the NF-κB pathway and by regulating key genes by modulating microRNA (miRNA) expression or the proteasomal pathway. In summary, EF24 is a promising anticancer compound with a unique mechanism of action that makes it effective against various cancers. Its ability to enhance the effects of conventional therapies, coupled with improvements in drug delivery systems, could make it a valuable asset in cancer treatment. However, addressing its solubility and stability challenges will be crucial for its successful clinical application.
EF24作为姜黄素的合成单羰基类似物，在化学预防与化学治疗方面均展现出显著的抗癌潜力。该化合物具有快速吸收、广泛组织分布及高效代谢的特点，能确保最佳生物利用度并维持靶组织的持续暴露。EF24穿透生物屏障并在肿瘤部位富集的能力，使其在癌症有效治疗中具有显著优势。研究表明，EF24对乳腺癌、肺癌、前列腺癌、结肠癌和胰腺癌等多种癌症均表现出卓越疗效。其独特作用机制涉及调控核因子κB（NF-κB）和核因子E2相关因子2（Nrf2）信号通路，从而破坏促癌性炎症与氧化应激反应。EF24主要通过抑制NF-κB通路，以及通过调节微小RNA（miRNA）表达或蛋白酶体通路调控关键基因，诱导细胞周期阻滞和细胞凋亡，进而抑制肿瘤生长。综上所述，EF24是一种具有独特作用机制的抗癌化合物，能有效对抗多种癌症。其增强常规疗法疗效的能力，结合药物递送系统的改进，可能使其成为癌症治疗中的重要资源。然而，解决其溶解性和稳定性问题对其成功临床应用至关重要。
肿瘤(癌症)患者之家